These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28408900)

  • 1. The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin.
    Varghese LN; Defour JP; Pecquet C; Constantinescu SN
    Front Endocrinol (Lausanne); 2017; 8():59. PubMed ID: 28408900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling.
    Wang Q; Sun R; Wu L; Huang J; Wang P; Yuan H; Qiu F; Xu X; Wu D; Yu Y; Liu X; Zhang Q
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2852-63. PubMed ID: 24144576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
    Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
    Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin from beginning to end.
    Hitchcock IS; Kaushansky K
    Br J Haematol; 2014 Apr; 165(2):259-68. PubMed ID: 24499199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia.
    Varghese LN; Zhang JG; Young SN; Willson TA; Alexander WS; Nicola NA; Babon JJ; Murphy JM
    Growth Factors; 2014 Feb; 32(1):18-26. PubMed ID: 24438083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
    Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
    Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG; Quentmeier H
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signals emanating from the membrane proximal region of the thrombopoietin receptor (mpl) support hematopoietic stem cell self-renewal.
    Tong W; Ibarra YM; Lodish HF
    Exp Hematol; 2007 Sep; 35(9):1447-55. PubMed ID: 17637498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia.
    Tijssen MR; di Summa F; van den Oudenrijn S; Zwaginga JJ; van der Schoot CE; Voermans C; de Haas M
    Br J Haematol; 2008 Jun; 141(6):808-13. PubMed ID: 18422784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
    Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
    Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
    Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
    Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin: biology and clinical potentials.
    Miyazaki H; Kato T
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the GPI-anchored receptor Prv-1 enhances thrombopoietin and IL-3-induced proliferation in hematopoietic cell lines.
    Dillon M; Minear J; Johnson J; Lannutti BJ
    Leuk Res; 2008 May; 32(5):811-9. PubMed ID: 17980909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
    Geddis AE; Fox NE; Kaushansky K
    Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways.
    Garcia J; de Gunzburg J; Eychène A; Gisselbrecht S; Porteu F
    Mol Cell Biol; 2001 Apr; 21(8):2659-70. PubMed ID: 11283246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
    Drexler HG; Quentmeier H
    Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology of the myeloproliferative disorders: the role of thrombopoietin.
    Kaushansky K
    Semin Hematol; 2003 Jan; 40(1 Suppl 1):6-9. PubMed ID: 12682875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In and out: Traffic and dynamics of thrombopoietin receptor.
    Roy A; Shrivastva S; Naseer S
    J Cell Mol Med; 2021 Oct; 25(19):9073-9083. PubMed ID: 34448528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin in thrombocytopenias of childhood.
    Dame C
    Semin Thromb Hemost; 2001 Jun; 27(3):215-28. PubMed ID: 11446655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations of calreticulin in myeloproliferative neoplasms.
    Klampfl T; Gisslinger H; Harutyunyan AS; Nivarthi H; Rumi E; Milosevic JD; Them NC; Berg T; Gisslinger B; Pietra D; Chen D; Vladimer GI; Bagienski K; Milanesi C; Casetti IC; Sant'Antonio E; Ferretti V; Elena C; Schischlik F; Cleary C; Six M; Schalling M; Schönegger A; Bock C; Malcovati L; Pascutto C; Superti-Furga G; Cazzola M; Kralovics R
    N Engl J Med; 2013 Dec; 369(25):2379-90. PubMed ID: 24325356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.